Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $0.96 in the prior trading day, Esperion Therapeutics Inc (NASDAQ: ESPR) closed at $1.02, up 6.25%. In other words, the price has increased by $6.25 from its previous closing price. On the day, 8.61 million shares were traded. ESPR stock price reached its highest trading level at $1.02 during the session, while it also had its lowest trading level at $0.95.
Ratios:
Our goal is to gain a better understanding of ESPR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’25 when Halladay Benjamin sold 3,535 shares for $1.48 per share. The transaction valued at 5,242 led to the insider holds 481,710 shares of the business.
Warren Eric sold 2,433 shares of ESPR for $3,618 on Mar 18 ’25. The Chief Commercial Officer now owns 370,326 shares after completing the transaction at $1.49 per share. On Mar 18 ’25, another insider, Koenig Sheldon L., who serves as the President and CEO of the company, sold 13,047 shares for $1.50 each. As a result, the insider received 19,623 and left with 1,571,962 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 201805968 and an Enterprise Value of 648256832. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61. Its current Enterprise Value per Revenue stands at 1.951 whereas that against EBITDA is 11.902.
Stock Price History:
The Beta on a monthly basis for ESPR is 0.85, which has changed by -0.47422683 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $0.93. The 50-Day Moving Average of the stock is -36.71%, while the 200-Day Moving Average is calculated to be -49.81%.
Shares Statistics:
The stock has traded on average 4.58M shares per day over the past 3-months and 7025620 shares per day over the last 10 days, according to various share statistics. A total of 195.85M shares are outstanding, with a floating share count of 194.37M. Insiders hold about 1.76% of the company’s shares, while institutions hold 58.83% stake in the company. Shares short for ESPR as of 1743379200 were 28023201 with a Short Ratio of 6.12, compared to 1740700800 on 29144177. Therefore, it implies a Short% of Shares Outstanding of 28023201 and a Short% of Float of 14.2.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
